SlideShare a Scribd company logo
Rheumatoid Arthritis
• Epidemiology
• Pathophysiology and clinical presentation
• Treatment
• Evaluation of treatment
• Clinical case
Epidemiology
 The prevalence estimated to be between 1% and 2% ,
with women affected 3 times more often than men
 Rheumatoid arthritis can occur at any age and often
occurs in younger people.
 Rheumatoid arthritis is an autoimmune disease with a
strong genetic predisposition.
Pathophysiology and clinical
presentation
Chronic inflammation of the synovial tissue lining the
joint capsule results in the proliferation of this tissue.
The inflamed proliferating synovium characteristic of
rheumatoid arthritis Is called pannus.
This panes invades the cartilage and eventually the
bone surface, producing erosions of bone and cartilage and
leading to destruction of the joint.
The factors that initiate the inflammatory process are unknown
The immune system is a
complex network of checks
and balances
designed to discriminate
self from non-self (foreign)
tissues.
It helps rid the body of
infectious agents, tumor
cells, and products
associated with the
breakdown of cells.
In rheumatoid arthritis, this
system no longer can
differentiate self from non-
self tissues and attacks the
synovial tissue and other
connective tissues
The immune system has both
humeral and cell-mediated
functions.
The humeral component is
necessary for the
formation of antibodies. These
antibodies are produced by
plasma
cells, which are derived from B
lymphocytes.
Most patientswith rheumatoid
arthritis form antibodies called
rheumatoid factors
Symptoms
■Joint pain and stiffness of more than 6 weeks’ duration
May also experience fatigue, weakness, low-grade fever,
Loss of appetite. Muscle pain and afternoon fatigue may also be
present.
Joint deformity is generally seen late in the disease.
Signs
■Tenderness with warmth and swelling over affected joints
usually involving hands and feet. Distribution of joint involvement
is frequently symmetrical. Rheumatoid nodules may also be
present
Laboratory Tests
■Rheumatoid factor (RF) detectable in 60% to 70%.
■Ant cyclic citrullinated peptide (anti-CCP) antibodieshave
similar sensitivity to RF (50% to 85%) but are morespecific
(90% to 95%) and are present earlier in the disease.
■Elevated erythrocyte sedimentation rate and C-reactive
protein are markers for inflammation.
■Normocytic normochromic anemia is common as is
thrombocytosis.
Other Diagnostic Tests
■Joint fluid aspiration may show
increased white blood cell
counts without infection, crystals.
■Joint radiographs may show
periarticular osteoporosis, joint
space narrowing, or erosions
EXTRAARTICULAR INVOLVEMENT
Rheumatoid Nodules
Vasculitis
Pulmonary Complications
Ocular Manifestations
Felty’s Syndrome
cardiac Involvement
Other Complications
LABORATORY FINDINGS
Normocytic normochromic anemia
Thrombocytosis
Leucopenia
ESR is elevated
C-reactive protein elevated
RF present in 60-70 % of patient
Anti- CCP antibody in 50-85%
Antinuclear antibodies in 25%
Diseases Associated with a
Positive
Rheumatoid Factor
Rheumatic diseases
Rheumatoid arthritis
Sjögren’s syndrome (with or without
arthritis)
Systemic lupus erythematosus
Progressive systemic sclerosis
Polymyositis/dermatomyositis
Infectious diseases
Bacterial endocarditis
Tuberculosis
Syphilis
Infectious mononucleosis
Infectious hepatitis
Leprosy
Other causes
Aging
Interstitial pulmonary fibrosis
Cirrhosis of the liver
Chronic active hepatitis
Sarcoidosis
TREATMENT
DESIRED OUTCOME
Control of inflammation is the key to slowing
or preventing disease progression as well
as managing symptoms
a. Reduction in the number of affected joints
and in joint tenderness and swelling
b. Improvement in pain
c. Decreased amount of morning stiffness
d. reduction in serological markers such as RF
e. Improvement in quality-of-life scales
NONPHARMACOLOGIC THERAPY
a. Rest during periods of disease exacerbation
b. Occupational and physical therapy to support
mobility and maintain function
c. Maintenance of normal weight to reduce
biomechanical stress on joints
d. Surgery (Tenosynovectomy, tendon repair,
And joint replacements).
e. Smoking Cessation
PHARMACOLOGIC THERAPY
Drug therapy should be only part of a
comprehensive program for patient management
which would also Include physical therapy,
exercise, and rest.
surgery may beAssistive devices and orthopedic
necessary in some patients
There are four types of medications used to treat RA:
Non-steroidal anti-inflammatory drugs (NSAIDs)
Corticosteroids
Disease-modifying anti-rheumatic drugs(DMARDS).
Biologic Response Modifiers (“Bioligics”)
 Disease-modifying antirheumatic drugs (DMARDs) or
biologic agents should be started within 3 months of the
diagnosis of rheumatoid arthritis.
Methotrexate ,hydroxycloroquine ,leflunomide ,and
sulphasalsine are commonly used as first line gents
 Nonsteroidal antiinflammatory drugs and/or corticosteroids
should be considered adjunctive therapy early in the course
of treatment and as needed if symptoms are not adequately
controlled with DMARDs.
When DMARDs used singly are ineffective or not
adequately effective, combination therapy with
two or more DMARDs or a
DMARD plus biologic agents may be used to
induce a response.
Patients require careful monitoring for toxicity and
therapeutic benefit for the duration of treatment
NSAIDs and/or corticosteroids may be used for
symptomatic relief if needed.
They provide relatively rapid improvement in
symptoms compared with DMARDs, which
may take weeks to months before benefit is
seen; however, NSAIDs have no impact on
disease progression and the long-term
complication risk of corticosteroids make
them less desirable
Non-steroidal anti-inflammatory drugs
(NSAIDs)
Examples General Use Side Effects Monitoring
Considerations
Aspirin, ibuprofen,
naproxen, COX-2
inhibitors, propionic acid,
phenylacetic acid
• anti-
inflammatory:
Used in the
management
inflammatory
conditions
•Antipyretic: used
to control fever
•Analgesic:
Control mild to
moderate pain
•Nausea
•Vomiting
•Diarrhea
•Constipation
•Dizziness
•Drowsiness
•Edema
•Kidney failure
•Liver failure
•Prolonged bleeding
•Ulcers
•Use cautiously in
patients with hx of
bleeding disorders
•Encourage pt to avoid
concurrent use of
alcohol
•NSAIDs may decrease
response to diuretics
or antihypertensive
therapy
(The Arthritis Society, 2011; Day et al., 2010)
Corticosteroids
 Used in bridging therapy
 Corticosteroids also may be delivered by
injection
 Patients on long-term therapy should be given
calcium and vitamin D or Alendronate to minimize
bone loss.
Examples General Use Side Effects monitoring
Considerations
Cortisone, hydrocortisone,
prednisone,
betamethasone,
dexa-methasone
• Used in the
management
inflammatory
conditions
•When NSAIDS
may be
contraindicated
•Promptly
improve
symptoms of RA
•Increased appetite
•Weight gain
•Water/salt retention
•Increased blood
pressure
•Thinning of skin
•Depression
•Mood swings
•Muscle weakness
•Osteoporosis
•Delayed wound
healing
•Onset/worsening of
diabetes
•Take medications as
directed (adrenal
suppression)
•Used with caution in
diabetic patients
•Encourage diet high
in protein, calcium,
potassium and low in
sodium and
carbohydrates
•Discuss body image
•Discuss risk for
infection
(The Arthritis Society, 2011; Day et al., 2010)
Disease-modifying anti-rheumatic drugs(DMARDS)
Examples General Use Side Effects Monitoring
Considerations
Methotrexate
Hydroxychloroquine
lefulinamide
(the gold standard)
, gold salts,
cyclosporine,
cyclophosphamide
sulfasalazine,
azathioprine
•immunosuppressive
activity
•Reduce inflammation of
rheumatoid arthritis
•Slows down joint
destruction
•Preserves joint function
•Dizziness, drowsiness,
headache
•Pulmonary fibrosis
•Pneumonitis
•Anorexia
•Nausea
•Hepatotoxicity
•Stomatitis
•Infertility
•Alopecia
•Skin ulceration
•Aplastic anemia
•Thrombocytopenia
•Leukopenia
•Nephropathy
•fever
•photosensitivity
•May take several
weeks to months
before they
become effective
•Discuss
teratogenicity,
should be taken off
drug several
months prior to
conception
•Discuss body
image
(The Arthritis Society, 2011; Day et al., 2010)
Methtrexate
 DMARD of choice
 CI in chronic liver disease,
immunodeficiency,thrpmpocytopenia,leucopenia,
 preexisting blood disorders , cr <40
 Inhibit cytokine production
 Git side effect , liver toxicity
 Folic acid antagonist
Dose and Administration
Dose ranges from 7.5 to 25 mg
ONLY GIVEN ONCE A WEEK
2.5 mg Tablets or Subcutaneous Injection 25
mg/mL
Tetrahydrofolate is an important cofactor in the production of purines
transferring a carbon atom
Biologic Response Modifiers (“Bioligics”)
 TNF Inhibitors
Adalimumab
Etanercept
Infliximab
 IL-1 Inhibitors
Anakinra
 T-Cell Co-Stimulatory Blockade
Abatacept
 B-Cell Depletion
Rituximab
Examples General Use Side Effects Nursing
Considerations
Etanercept,
anakinra,
abatacipt,
adalimumab,
Infliximab (Remicade)
• Used in the
management
inflammatory
conditions
•When NSAIDS
may be
contraindicated
•Promptly
improve
symptoms of RA
•Increased appetite
•Weight gain
•Water/salt retention
•Increased blood
pressure
•Thinning of skin
•Depression
•Mood swings
•Muscle weakness
•Osteoporosis
•Delayed wound
healing
•Onset/worsening of
diabetes
•Take medications as
directed (adrenal
suppression)
•Encourage diet high
in protein, calcium,
potassium and low in
sodium and
carbohydrates
•Discuss body image
•Discuss risk for
infection
Therapeutic guideline
Triple Therapy
Methotrexate, Sulfasalazine, Hydroxychloroquine
Double Therapy
Methotrexate & Leflunomide
Methotrexate & Sulfasalazine
Methotrexate & Hydroxychloroquine
Methotrexate & infliximab
Sulfasalazine & cyclosporin
Dosing
EVALUATION OF THERAPEUTIC OUTCOMES
The evaluation of therapeutic outcomes is based primarily on
improvements of clinical signs and symptoms of rheumatoid
arthritis.
Clinical signs of improvement include a reduction in joint swelling,
decreased warmth over actively involvedjoints, and decreased
tenderness to joint palpation. Improvement in rheumatoid arthritis
symptoms includes reduction in perceived joint pain and morning
stiffness, longer time to onset of afternoon fatigue, and
improvement in ability to perform activities of daily living.
Improvement of activities of daily living may be assessed
objectively using a Health Assessment Questionnaire score.
.
Joint radiographs may be of some benefit in assessing the
progression of the disease and should show little or no
evidence of disease progression if treatment is effective.
Laboratory monitoring is of little value in monitoring individual
patient response to therapy. Routine monitoring of patients is
essential to the safe use of these drugs.
In addition, patients should be questioned about
symptoms of the adverse effects outlined previously
Rheumatoid arthritis
Rheumatoid arthritis
Rheumatoid arthritis

More Related Content

What's hot

Rheumatoid Arthritis
Rheumatoid ArthritisRheumatoid Arthritis
Rheumatoid Arthritis
Eneutron
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
Julie Jane
 
RHEUMATOID ARTHRITIS
RHEUMATOID ARTHRITISRHEUMATOID ARTHRITIS
RHEUMATOID ARTHRITIS
aishuanju
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
swathisravani
 
RHEUMATOID ARTHRITIS
RHEUMATOID ARTHRITISRHEUMATOID ARTHRITIS
RHEUMATOID ARTHRITISshruti87
 
Rhumatoide arthritis
Rhumatoide arthritisRhumatoide arthritis
Rhumatoide arthritis
paras suthar
 
RA Rheumatoid Arthritis
RA Rheumatoid ArthritisRA Rheumatoid Arthritis
RA Rheumatoid Arthritis
HuzaifaMD
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
Diana Girnita
 
Rheumatic Disorders Part I
Rheumatic Disorders Part IRheumatic Disorders Part I
Rheumatic Disorders Part I
Carmela Domocmat
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
keerthi samuel
 
gout
goutgout
RHEUMATOID ARTHRITIS
RHEUMATOID ARTHRITISRHEUMATOID ARTHRITIS
RHEUMATOID ARTHRITIS
VaibhawPatel1
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
Rounak Bhandari
 
Rheumatoid arthritis nov 2020
Rheumatoid arthritis nov 2020Rheumatoid arthritis nov 2020
Rheumatoid arthritis nov 2020
Mukiza1
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritisPHAM HUU THAI
 
Osteoarthritis
OsteoarthritisOsteoarthritis
Osteoarthritis
sudarshan731
 
Rheumatoid Arthritis
Rheumatoid ArthritisRheumatoid Arthritis
Rheumatoid Arthritis
Gajanan Pandit
 
Psoriatic arthritis
Psoriatic arthritisPsoriatic arthritis
Psoriatic arthritis
hamidreza227
 
Osteoarthritis
OsteoarthritisOsteoarthritis
Osteoarthritis
Bapan Paul
 

What's hot (20)

rheumatoid arthritis
rheumatoid arthritisrheumatoid arthritis
rheumatoid arthritis
 
Rheumatoid Arthritis
Rheumatoid ArthritisRheumatoid Arthritis
Rheumatoid Arthritis
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
RHEUMATOID ARTHRITIS
RHEUMATOID ARTHRITISRHEUMATOID ARTHRITIS
RHEUMATOID ARTHRITIS
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
RHEUMATOID ARTHRITIS
RHEUMATOID ARTHRITISRHEUMATOID ARTHRITIS
RHEUMATOID ARTHRITIS
 
Rhumatoide arthritis
Rhumatoide arthritisRhumatoide arthritis
Rhumatoide arthritis
 
RA Rheumatoid Arthritis
RA Rheumatoid ArthritisRA Rheumatoid Arthritis
RA Rheumatoid Arthritis
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
Rheumatic Disorders Part I
Rheumatic Disorders Part IRheumatic Disorders Part I
Rheumatic Disorders Part I
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
gout
goutgout
gout
 
RHEUMATOID ARTHRITIS
RHEUMATOID ARTHRITISRHEUMATOID ARTHRITIS
RHEUMATOID ARTHRITIS
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
Rheumatoid arthritis nov 2020
Rheumatoid arthritis nov 2020Rheumatoid arthritis nov 2020
Rheumatoid arthritis nov 2020
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
Osteoarthritis
OsteoarthritisOsteoarthritis
Osteoarthritis
 
Rheumatoid Arthritis
Rheumatoid ArthritisRheumatoid Arthritis
Rheumatoid Arthritis
 
Psoriatic arthritis
Psoriatic arthritisPsoriatic arthritis
Psoriatic arthritis
 
Osteoarthritis
OsteoarthritisOsteoarthritis
Osteoarthritis
 

Viewers also liked

Rheumatoid arthritis ppt by ann..
Rheumatoid arthritis ppt by ann..Rheumatoid arthritis ppt by ann..
Rheumatoid arthritis ppt by ann..
Anjali Rarichan
 
Rheumatoid arthritis current diagnosis and treatment
Rheumatoid arthritis current diagnosis and treatmentRheumatoid arthritis current diagnosis and treatment
Rheumatoid arthritis current diagnosis and treatment
Ankur Varshney
 
Rheumatoid arthritis pathogenesis
Rheumatoid arthritis  pathogenesisRheumatoid arthritis  pathogenesis
Rheumatoid arthritis pathogenesis
Venkata pradeep babu koyyala
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
Pratap Tiwari
 
BIOLOGICS IN RHEUMATOID ARTHRITIS
BIOLOGICS IN RHEUMATOID ARTHRITISBIOLOGICS IN RHEUMATOID ARTHRITIS
BIOLOGICS IN RHEUMATOID ARTHRITIS
Dr. Sachin Kumar
 
Rheumatoid arthritis for undergraduates
Rheumatoid arthritis for undergraduatesRheumatoid arthritis for undergraduates
Rheumatoid arthritis for undergraduatesDhananjaya Sabat
 
Core course lecture - Rheumatoid Arthritis
Core course lecture - Rheumatoid ArthritisCore course lecture - Rheumatoid Arthritis
Core course lecture - Rheumatoid Arthritis
NES
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
Baljinder Singh
 
rheumatoid arthritis
rheumatoid arthritisrheumatoid arthritis
rheumatoid arthritis
Ashwini Somayaji
 
Pharmacotherapy of Rheumatoid arthritis
Pharmacotherapy of Rheumatoid arthritisPharmacotherapy of Rheumatoid arthritis
Pharmacotherapy of Rheumatoid arthritis
Koppala RVS Chaitanya
 
RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...
RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...
RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...
Prof Dr Bashir Ahmed Dar
 
Rheumatoid Arthritis Power Point
Rheumatoid Arthritis Power PointRheumatoid Arthritis Power Point
Rheumatoid Arthritis Power Point
steverluce
 
Rheumatoid arthritis and osteoarthritis
Rheumatoid arthritis and osteoarthritisRheumatoid arthritis and osteoarthritis
Rheumatoid arthritis and osteoarthritis
Sonal Saran
 
12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of J...
12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of J...12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of J...
12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of J...
Open.Michigan
 
RHEUMATOID ARTHRITIS OF SPINE
RHEUMATOID ARTHRITIS OF SPINERHEUMATOID ARTHRITIS OF SPINE
RHEUMATOID ARTHRITIS OF SPINE
Nizar Abdul
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
mpattani
 
Rheumatoid arthritis
Rheumatoid arthritis Rheumatoid arthritis
Rheumatoid arthritis
Harsh Chunara
 
Santiago[1]
Santiago[1]Santiago[1]
Schizophrenia & gangguan bipolar
Schizophrenia & gangguan bipolarSchizophrenia & gangguan bipolar
Schizophrenia & gangguan bipolarfta_triastuti
 
Rheumatoid arthritis pdf
Rheumatoid arthritis pdfRheumatoid arthritis pdf
Rheumatoid arthritis pdf
Jeremiah Laichena
 

Viewers also liked (20)

Rheumatoid arthritis ppt by ann..
Rheumatoid arthritis ppt by ann..Rheumatoid arthritis ppt by ann..
Rheumatoid arthritis ppt by ann..
 
Rheumatoid arthritis current diagnosis and treatment
Rheumatoid arthritis current diagnosis and treatmentRheumatoid arthritis current diagnosis and treatment
Rheumatoid arthritis current diagnosis and treatment
 
Rheumatoid arthritis pathogenesis
Rheumatoid arthritis  pathogenesisRheumatoid arthritis  pathogenesis
Rheumatoid arthritis pathogenesis
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
BIOLOGICS IN RHEUMATOID ARTHRITIS
BIOLOGICS IN RHEUMATOID ARTHRITISBIOLOGICS IN RHEUMATOID ARTHRITIS
BIOLOGICS IN RHEUMATOID ARTHRITIS
 
Rheumatoid arthritis for undergraduates
Rheumatoid arthritis for undergraduatesRheumatoid arthritis for undergraduates
Rheumatoid arthritis for undergraduates
 
Core course lecture - Rheumatoid Arthritis
Core course lecture - Rheumatoid ArthritisCore course lecture - Rheumatoid Arthritis
Core course lecture - Rheumatoid Arthritis
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
rheumatoid arthritis
rheumatoid arthritisrheumatoid arthritis
rheumatoid arthritis
 
Pharmacotherapy of Rheumatoid arthritis
Pharmacotherapy of Rheumatoid arthritisPharmacotherapy of Rheumatoid arthritis
Pharmacotherapy of Rheumatoid arthritis
 
RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...
RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...
RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...
 
Rheumatoid Arthritis Power Point
Rheumatoid Arthritis Power PointRheumatoid Arthritis Power Point
Rheumatoid Arthritis Power Point
 
Rheumatoid arthritis and osteoarthritis
Rheumatoid arthritis and osteoarthritisRheumatoid arthritis and osteoarthritis
Rheumatoid arthritis and osteoarthritis
 
12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of J...
12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of J...12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of J...
12.01.08(a): Rheumatoid Arthritis/Pathogenesis and Clinical Presentation of J...
 
RHEUMATOID ARTHRITIS OF SPINE
RHEUMATOID ARTHRITIS OF SPINERHEUMATOID ARTHRITIS OF SPINE
RHEUMATOID ARTHRITIS OF SPINE
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Rheumatoid arthritis
Rheumatoid arthritis Rheumatoid arthritis
Rheumatoid arthritis
 
Santiago[1]
Santiago[1]Santiago[1]
Santiago[1]
 
Schizophrenia & gangguan bipolar
Schizophrenia & gangguan bipolarSchizophrenia & gangguan bipolar
Schizophrenia & gangguan bipolar
 
Rheumatoid arthritis pdf
Rheumatoid arthritis pdfRheumatoid arthritis pdf
Rheumatoid arthritis pdf
 

Similar to Rheumatoid arthritis

1. Anti-Rheumatic Agents.pptx
1. Anti-Rheumatic Agents.pptx1. Anti-Rheumatic Agents.pptx
1. Anti-Rheumatic Agents.pptx
HarshikaPatel6
 
Rhumatoid Arthritis
Rhumatoid ArthritisRhumatoid Arthritis
Rhumatoid Arthritis
Immanuel Jebastine M
 
Rheumatois arthritis , pain management..
Rheumatois arthritis , pain management..Rheumatois arthritis , pain management..
Rheumatois arthritis , pain management..
Dr Ravi Shankar Sharma
 
Rheumatoid arthritis - Musculoskeletal disorders.ppt
Rheumatoid arthritis - Musculoskeletal disorders.pptRheumatoid arthritis - Musculoskeletal disorders.ppt
Rheumatoid arthritis - Musculoskeletal disorders.ppt
raviapr7
 
Anti-Rheumatic drugs
Anti-Rheumatic drugsAnti-Rheumatic drugs
Anti-Rheumatic drugs
JagirPatel3
 
Role of Tofacitinib in Rheumatoid Arthritis
Role of Tofacitinib in Rheumatoid ArthritisRole of Tofacitinib in Rheumatoid Arthritis
Role of Tofacitinib in Rheumatoid Arthritis
Dr Bodhisatwa Choudhuri
 
Rheumatoid Arthritis for Medical and Pharmacy Students
Rheumatoid Arthritis for Medical and Pharmacy StudentsRheumatoid Arthritis for Medical and Pharmacy Students
Rheumatoid Arthritis for Medical and Pharmacy Students
arun chand roby
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
Andualem Kibatu
 
SLE.ppt.pptx
SLE.ppt.pptxSLE.ppt.pptx
SLE.ppt.pptx
SaakshiDeokar
 
L35-Rheumatoid and Osteoarthritis nursing .pptx
L35-Rheumatoid and Osteoarthritis nursing .pptxL35-Rheumatoid and Osteoarthritis nursing .pptx
L35-Rheumatoid and Osteoarthritis nursing .pptx
ssuser47b89a
 
2018 Q4 Rheumatoid Arthritis Management.pptx
2018 Q4 Rheumatoid Arthritis Management.pptx2018 Q4 Rheumatoid Arthritis Management.pptx
2018 Q4 Rheumatoid Arthritis Management.pptx
javakhirMuradov
 
systemic lupus erythematosus
systemic lupus  erythematosussystemic lupus  erythematosus
systemic lupus erythematosus
Kirsha K S
 
DMARDs
DMARDsDMARDs
final_rheumatoid_arthritis.ppt
final_rheumatoid_arthritis.pptfinal_rheumatoid_arthritis.ppt
final_rheumatoid_arthritis.ppt
aartichande
 
final rheumatoid arthritis medical .ppt
final rheumatoid arthritis medical  .pptfinal rheumatoid arthritis medical  .ppt
final rheumatoid arthritis medical .ppt
Shivani Bhardwaj
 
final_rheumatoid_arthritis.ppt
final_rheumatoid_arthritis.pptfinal_rheumatoid_arthritis.ppt
final_rheumatoid_arthritis.ppt
neeti70
 
Antirheumatic drugs
Antirheumatic drugsAntirheumatic drugs
Antirheumatic drugs
Dr. Marya Ahsan
 
Final rheumatoid arthritis
Final rheumatoid arthritisFinal rheumatoid arthritis
Final rheumatoid arthritis
Amer
 
Final rheumatoid arthritis
Final rheumatoid arthritisFinal rheumatoid arthritis
Final rheumatoid arthritis
Amer
 
Candid Conversations in Lupus: Navigating Advances in Diagnosis and Treatment...
Candid Conversations in Lupus: Navigating Advances in Diagnosis and Treatment...Candid Conversations in Lupus: Navigating Advances in Diagnosis and Treatment...
Candid Conversations in Lupus: Navigating Advances in Diagnosis and Treatment...
PVI, PeerView Institute for Medical Education
 

Similar to Rheumatoid arthritis (20)

1. Anti-Rheumatic Agents.pptx
1. Anti-Rheumatic Agents.pptx1. Anti-Rheumatic Agents.pptx
1. Anti-Rheumatic Agents.pptx
 
Rhumatoid Arthritis
Rhumatoid ArthritisRhumatoid Arthritis
Rhumatoid Arthritis
 
Rheumatois arthritis , pain management..
Rheumatois arthritis , pain management..Rheumatois arthritis , pain management..
Rheumatois arthritis , pain management..
 
Rheumatoid arthritis - Musculoskeletal disorders.ppt
Rheumatoid arthritis - Musculoskeletal disorders.pptRheumatoid arthritis - Musculoskeletal disorders.ppt
Rheumatoid arthritis - Musculoskeletal disorders.ppt
 
Anti-Rheumatic drugs
Anti-Rheumatic drugsAnti-Rheumatic drugs
Anti-Rheumatic drugs
 
Role of Tofacitinib in Rheumatoid Arthritis
Role of Tofacitinib in Rheumatoid ArthritisRole of Tofacitinib in Rheumatoid Arthritis
Role of Tofacitinib in Rheumatoid Arthritis
 
Rheumatoid Arthritis for Medical and Pharmacy Students
Rheumatoid Arthritis for Medical and Pharmacy StudentsRheumatoid Arthritis for Medical and Pharmacy Students
Rheumatoid Arthritis for Medical and Pharmacy Students
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
SLE.ppt.pptx
SLE.ppt.pptxSLE.ppt.pptx
SLE.ppt.pptx
 
L35-Rheumatoid and Osteoarthritis nursing .pptx
L35-Rheumatoid and Osteoarthritis nursing .pptxL35-Rheumatoid and Osteoarthritis nursing .pptx
L35-Rheumatoid and Osteoarthritis nursing .pptx
 
2018 Q4 Rheumatoid Arthritis Management.pptx
2018 Q4 Rheumatoid Arthritis Management.pptx2018 Q4 Rheumatoid Arthritis Management.pptx
2018 Q4 Rheumatoid Arthritis Management.pptx
 
systemic lupus erythematosus
systemic lupus  erythematosussystemic lupus  erythematosus
systemic lupus erythematosus
 
DMARDs
DMARDsDMARDs
DMARDs
 
final_rheumatoid_arthritis.ppt
final_rheumatoid_arthritis.pptfinal_rheumatoid_arthritis.ppt
final_rheumatoid_arthritis.ppt
 
final rheumatoid arthritis medical .ppt
final rheumatoid arthritis medical  .pptfinal rheumatoid arthritis medical  .ppt
final rheumatoid arthritis medical .ppt
 
final_rheumatoid_arthritis.ppt
final_rheumatoid_arthritis.pptfinal_rheumatoid_arthritis.ppt
final_rheumatoid_arthritis.ppt
 
Antirheumatic drugs
Antirheumatic drugsAntirheumatic drugs
Antirheumatic drugs
 
Final rheumatoid arthritis
Final rheumatoid arthritisFinal rheumatoid arthritis
Final rheumatoid arthritis
 
Final rheumatoid arthritis
Final rheumatoid arthritisFinal rheumatoid arthritis
Final rheumatoid arthritis
 
Candid Conversations in Lupus: Navigating Advances in Diagnosis and Treatment...
Candid Conversations in Lupus: Navigating Advances in Diagnosis and Treatment...Candid Conversations in Lupus: Navigating Advances in Diagnosis and Treatment...
Candid Conversations in Lupus: Navigating Advances in Diagnosis and Treatment...
 

Recently uploaded

Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 

Recently uploaded (20)

Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 

Rheumatoid arthritis

  • 2. • Epidemiology • Pathophysiology and clinical presentation • Treatment • Evaluation of treatment • Clinical case
  • 4.  The prevalence estimated to be between 1% and 2% , with women affected 3 times more often than men  Rheumatoid arthritis can occur at any age and often occurs in younger people.  Rheumatoid arthritis is an autoimmune disease with a strong genetic predisposition.
  • 6. Chronic inflammation of the synovial tissue lining the joint capsule results in the proliferation of this tissue. The inflamed proliferating synovium characteristic of rheumatoid arthritis Is called pannus. This panes invades the cartilage and eventually the bone surface, producing erosions of bone and cartilage and leading to destruction of the joint. The factors that initiate the inflammatory process are unknown
  • 7.
  • 8.
  • 9.
  • 10. The immune system is a complex network of checks and balances designed to discriminate self from non-self (foreign) tissues. It helps rid the body of infectious agents, tumor cells, and products associated with the breakdown of cells. In rheumatoid arthritis, this system no longer can differentiate self from non- self tissues and attacks the synovial tissue and other connective tissues
  • 11.
  • 12. The immune system has both humeral and cell-mediated functions. The humeral component is necessary for the formation of antibodies. These antibodies are produced by plasma cells, which are derived from B lymphocytes. Most patientswith rheumatoid arthritis form antibodies called rheumatoid factors
  • 13. Symptoms ■Joint pain and stiffness of more than 6 weeks’ duration May also experience fatigue, weakness, low-grade fever, Loss of appetite. Muscle pain and afternoon fatigue may also be present. Joint deformity is generally seen late in the disease. Signs ■Tenderness with warmth and swelling over affected joints usually involving hands and feet. Distribution of joint involvement is frequently symmetrical. Rheumatoid nodules may also be present
  • 14. Laboratory Tests ■Rheumatoid factor (RF) detectable in 60% to 70%. ■Ant cyclic citrullinated peptide (anti-CCP) antibodieshave similar sensitivity to RF (50% to 85%) but are morespecific (90% to 95%) and are present earlier in the disease. ■Elevated erythrocyte sedimentation rate and C-reactive protein are markers for inflammation. ■Normocytic normochromic anemia is common as is thrombocytosis.
  • 15. Other Diagnostic Tests ■Joint fluid aspiration may show increased white blood cell counts without infection, crystals. ■Joint radiographs may show periarticular osteoporosis, joint space narrowing, or erosions
  • 16. EXTRAARTICULAR INVOLVEMENT Rheumatoid Nodules Vasculitis Pulmonary Complications Ocular Manifestations Felty’s Syndrome cardiac Involvement Other Complications
  • 17. LABORATORY FINDINGS Normocytic normochromic anemia Thrombocytosis Leucopenia ESR is elevated C-reactive protein elevated RF present in 60-70 % of patient Anti- CCP antibody in 50-85% Antinuclear antibodies in 25%
  • 18. Diseases Associated with a Positive Rheumatoid Factor Rheumatic diseases Rheumatoid arthritis Sjögren’s syndrome (with or without arthritis) Systemic lupus erythematosus Progressive systemic sclerosis Polymyositis/dermatomyositis Infectious diseases Bacterial endocarditis Tuberculosis Syphilis Infectious mononucleosis Infectious hepatitis Leprosy Other causes Aging Interstitial pulmonary fibrosis Cirrhosis of the liver Chronic active hepatitis Sarcoidosis
  • 20. DESIRED OUTCOME Control of inflammation is the key to slowing or preventing disease progression as well as managing symptoms
  • 21. a. Reduction in the number of affected joints and in joint tenderness and swelling b. Improvement in pain c. Decreased amount of morning stiffness d. reduction in serological markers such as RF e. Improvement in quality-of-life scales
  • 22. NONPHARMACOLOGIC THERAPY a. Rest during periods of disease exacerbation b. Occupational and physical therapy to support mobility and maintain function c. Maintenance of normal weight to reduce biomechanical stress on joints d. Surgery (Tenosynovectomy, tendon repair, And joint replacements). e. Smoking Cessation
  • 23. PHARMACOLOGIC THERAPY Drug therapy should be only part of a comprehensive program for patient management which would also Include physical therapy, exercise, and rest. surgery may beAssistive devices and orthopedic necessary in some patients
  • 24. There are four types of medications used to treat RA: Non-steroidal anti-inflammatory drugs (NSAIDs) Corticosteroids Disease-modifying anti-rheumatic drugs(DMARDS). Biologic Response Modifiers (“Bioligics”)
  • 25.  Disease-modifying antirheumatic drugs (DMARDs) or biologic agents should be started within 3 months of the diagnosis of rheumatoid arthritis. Methotrexate ,hydroxycloroquine ,leflunomide ,and sulphasalsine are commonly used as first line gents  Nonsteroidal antiinflammatory drugs and/or corticosteroids should be considered adjunctive therapy early in the course of treatment and as needed if symptoms are not adequately controlled with DMARDs.
  • 26. When DMARDs used singly are ineffective or not adequately effective, combination therapy with two or more DMARDs or a DMARD plus biologic agents may be used to induce a response. Patients require careful monitoring for toxicity and therapeutic benefit for the duration of treatment
  • 27. NSAIDs and/or corticosteroids may be used for symptomatic relief if needed. They provide relatively rapid improvement in symptoms compared with DMARDs, which may take weeks to months before benefit is seen; however, NSAIDs have no impact on disease progression and the long-term complication risk of corticosteroids make them less desirable
  • 29. Examples General Use Side Effects Monitoring Considerations Aspirin, ibuprofen, naproxen, COX-2 inhibitors, propionic acid, phenylacetic acid • anti- inflammatory: Used in the management inflammatory conditions •Antipyretic: used to control fever •Analgesic: Control mild to moderate pain •Nausea •Vomiting •Diarrhea •Constipation •Dizziness •Drowsiness •Edema •Kidney failure •Liver failure •Prolonged bleeding •Ulcers •Use cautiously in patients with hx of bleeding disorders •Encourage pt to avoid concurrent use of alcohol •NSAIDs may decrease response to diuretics or antihypertensive therapy (The Arthritis Society, 2011; Day et al., 2010)
  • 31.  Used in bridging therapy  Corticosteroids also may be delivered by injection  Patients on long-term therapy should be given calcium and vitamin D or Alendronate to minimize bone loss.
  • 32. Examples General Use Side Effects monitoring Considerations Cortisone, hydrocortisone, prednisone, betamethasone, dexa-methasone • Used in the management inflammatory conditions •When NSAIDS may be contraindicated •Promptly improve symptoms of RA •Increased appetite •Weight gain •Water/salt retention •Increased blood pressure •Thinning of skin •Depression •Mood swings •Muscle weakness •Osteoporosis •Delayed wound healing •Onset/worsening of diabetes •Take medications as directed (adrenal suppression) •Used with caution in diabetic patients •Encourage diet high in protein, calcium, potassium and low in sodium and carbohydrates •Discuss body image •Discuss risk for infection (The Arthritis Society, 2011; Day et al., 2010)
  • 34. Examples General Use Side Effects Monitoring Considerations Methotrexate Hydroxychloroquine lefulinamide (the gold standard) , gold salts, cyclosporine, cyclophosphamide sulfasalazine, azathioprine •immunosuppressive activity •Reduce inflammation of rheumatoid arthritis •Slows down joint destruction •Preserves joint function •Dizziness, drowsiness, headache •Pulmonary fibrosis •Pneumonitis •Anorexia •Nausea •Hepatotoxicity •Stomatitis •Infertility •Alopecia •Skin ulceration •Aplastic anemia •Thrombocytopenia •Leukopenia •Nephropathy •fever •photosensitivity •May take several weeks to months before they become effective •Discuss teratogenicity, should be taken off drug several months prior to conception •Discuss body image (The Arthritis Society, 2011; Day et al., 2010)
  • 35. Methtrexate  DMARD of choice  CI in chronic liver disease, immunodeficiency,thrpmpocytopenia,leucopenia,  preexisting blood disorders , cr <40  Inhibit cytokine production  Git side effect , liver toxicity  Folic acid antagonist Dose and Administration Dose ranges from 7.5 to 25 mg ONLY GIVEN ONCE A WEEK 2.5 mg Tablets or Subcutaneous Injection 25 mg/mL
  • 36.
  • 37. Tetrahydrofolate is an important cofactor in the production of purines transferring a carbon atom
  • 38. Biologic Response Modifiers (“Bioligics”)
  • 39.
  • 40.
  • 41.  TNF Inhibitors Adalimumab Etanercept Infliximab  IL-1 Inhibitors Anakinra  T-Cell Co-Stimulatory Blockade Abatacept  B-Cell Depletion Rituximab
  • 42. Examples General Use Side Effects Nursing Considerations Etanercept, anakinra, abatacipt, adalimumab, Infliximab (Remicade) • Used in the management inflammatory conditions •When NSAIDS may be contraindicated •Promptly improve symptoms of RA •Increased appetite •Weight gain •Water/salt retention •Increased blood pressure •Thinning of skin •Depression •Mood swings •Muscle weakness •Osteoporosis •Delayed wound healing •Onset/worsening of diabetes •Take medications as directed (adrenal suppression) •Encourage diet high in protein, calcium, potassium and low in sodium and carbohydrates •Discuss body image •Discuss risk for infection
  • 44.
  • 45. Triple Therapy Methotrexate, Sulfasalazine, Hydroxychloroquine Double Therapy Methotrexate & Leflunomide Methotrexate & Sulfasalazine Methotrexate & Hydroxychloroquine Methotrexate & infliximab Sulfasalazine & cyclosporin
  • 47.
  • 48. EVALUATION OF THERAPEUTIC OUTCOMES The evaluation of therapeutic outcomes is based primarily on improvements of clinical signs and symptoms of rheumatoid arthritis. Clinical signs of improvement include a reduction in joint swelling, decreased warmth over actively involvedjoints, and decreased tenderness to joint palpation. Improvement in rheumatoid arthritis symptoms includes reduction in perceived joint pain and morning stiffness, longer time to onset of afternoon fatigue, and improvement in ability to perform activities of daily living. Improvement of activities of daily living may be assessed objectively using a Health Assessment Questionnaire score. .
  • 49. Joint radiographs may be of some benefit in assessing the progression of the disease and should show little or no evidence of disease progression if treatment is effective. Laboratory monitoring is of little value in monitoring individual patient response to therapy. Routine monitoring of patients is essential to the safe use of these drugs. In addition, patients should be questioned about symptoms of the adverse effects outlined previously